Description
The National Institute on Aging (NIA) seeks quotations for a brand‑name or equal multiplexed precision proteomics immunoassay panel (NULISAseq Neuro 220 Panel) and associated bulk reagents (NULISA 10X Wash Buffer) to support biomarker research in neurodegenerative disease and chronic pain. Seven panels and two wash‑buffer kits are required, with delivery within 30 days to NIA’s Baltimore facility. The award will be based on technical capability, price, and past performance, with technical factors weighted more heavily. The solicitation is an RFQ under FAR Part 12, not set‑aside for small businesses.
• Quantity: 7 × NULISAseq Neuro 220 Panels, 2 × NULISA 10X Wash Buffers.
• Compatibility: Must work with ARGO HT System (automated, high‑throughput).
• Technical requirements: attomolar sensitivity, >12‑log dynamic range, >220 biomarkers per 25 µL sample.
• Delivery: within 30 days of order receipt, to 251 Bayview Blvd, Baltimore, MD 21224.
• Evaluation criteria: technical capability (major), price, past performance.
• Submission deadline: 1:00 p.m. EDT, 14 Sept 2026; electronic submission to Lisa Anglin and Josh Lazarus.